Note 16 - Segments and Geographic Areas

6 Months Ended

Jun. 30, 2024

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

16. Segments and Geographic Areas

The Company operates in one business segment—the research, development, and sale of medical devices to improve minimally invasive surgery. The Company’s chief operating decision maker (determined to be the Chief Executive Officer) does not manage any part of the Company separately, and the allocation of resources and assessment of performance are based on the Company’s consolidated operating results.

The following table presents long-lived assets (which include property and equipment and operating lease assets) by geographic area:

	June 30, 2024			December 31, 2023
U.S.		28	%		29	%
EMEA		70	%		68	%
Asia		2	%		3	%
Total		100	%		100	%

The following table presents revenue by geographic area based on the country in which the customer is based:

	Three Months Ended June 30,						Six Months Ended June 30,
	2024			2023			2024			2023
US		8	%		12	%		12	%		16	%
EMEA		84	%		67	%		77	%		62	%
Asia		8	%		21	%		11	%		22	%
Total		100	%		100	%		100	%		100	%

For the three months ended June 30, 2024, the Company had two customers who accounted for 43% and 11% of revenue. For the six months ended June 30, 2024, the Company had one customer who accounted for 28%. For the three months ended June 30, 2023, the Company had no customers who accounted for more than 10% of revenue.